Estimated longevity benefit: +1.3 years. Evidence score: 46/100.
17-alpha-estradiol is a non-feminizing estrogen isomer that modulates metabolic and inflammatory pathways by binding to non-classical receptors. This targeted metabolic reprogramming addresses male-specific biological decline and has demonstrated consistent lifespan extension in animal models.